Other Assets, Noncurrent in USD of ATOSSA THERAPEUTICS, INC. from Q4 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
ATOSSA THERAPEUTICS, INC. quarterly Other Assets, Noncurrent history and change rate from Q4 2011 to Q3 2025.
  • ATOSSA THERAPEUTICS, INC. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $2.33M, a 1.35% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

ATOSSA THERAPEUTICS, INC. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $2.33M -$32K -1.35% 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $2M -$432K -17.8% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $2M -$319K -13.7% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $1.99M -$336K -14.5% 31 Dec 2024 10-Q 12 Nov 2025
Q3 2024 $2.37M +$29K +1.24% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $2.43M +$1.79M +279% 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $2.32M +$1.69M +268% 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $2.32M +$1.69M +266% 31 Dec 2023 10-K 25 Mar 2025
Q3 2023 $2.34M +$1.71M +272% 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $642K +$15K +2.39% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $631K +$1K +0.16% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $635K +$613K +2786% 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 $629K +$616K +4591% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $627K +$614K +4576% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 $630K +$614K +3726% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $22K +$5K +29.4% 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 $13.4K -$3.81K -22.1% 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 $13.4K -$3.81K -22.1% 30 Jun 2021 10-Q 13 Aug 2021
Q1 2021 $16.5K -$750 -4.36% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 $17K -$218 -1.27% 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 $17.2K $0 0% 30 Sep 2020 10-Q 13 Nov 2020
Q2 2020 $17.2K $0 0% 30 Jun 2020 10-Q 13 Aug 2020
Q1 2020 $17.2K $0 0% 31 Mar 2020 10-Q 13 May 2020
Q4 2019 $17.2K $0 0% 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 $17.2K -$71.3K -80.5% 30 Sep 2019 10-Q 13 Nov 2019
Q2 2019 $17.2K -$31.6K -64.8% 30 Jun 2019 10-Q 13 Aug 2019
Q1 2019 $17.2K -$97.4K -85% 31 Mar 2019 10-Q 13 May 2019
Q4 2018 $17.2K -$162K -90.4% 31 Dec 2018 10-K 26 Mar 2020
Q3 2018 $88.5K -$20.2K -18.6% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $48.9K -$79.7K -62% 30 Jun 2018 10-Q/A 13 Nov 2018
Q1 2018 $115K -$34K -22.9% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 $179K -$15.3K -7.9% 31 Dec 2017 10-K 28 Mar 2019
Q3 2017 $109K -$119K -52.3% 30 Sep 2017 10-Q 13 Nov 2017
Q2 2017 $129K -$140K -52.1% 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 $149K +$72.2K +94.6% 31 Mar 2017 10-Q 11 May 2017
Q4 2016 $194K +$118K +154% 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 $228K +$175K +333% 30 Sep 2016 10-Q/A 21 Mar 2017
Q2 2016 $268K +$216K +410% 30 Jun 2016 10-Q/A 21 Mar 2017
Q1 2016 $76.3K -$100K -56.8% 31 Mar 2016 10-Q/A 21 Mar 2017
Q4 2015 $76.3K +$28.1K +58.4% 31 Dec 2015 10-Q/A 21 Mar 2017
Q3 2015 $52.6K 30 Sep 2015 10-Q 12 Nov 2015
Q2 2015 $52.6K 30 Jun 2015 10-Q 06 Aug 2015
Q1 2015 $177K -$4.38M -96.1% 31 Mar 2015 10-Q 13 May 2015
Q4 2014 $48.2K +$11.7K +32.2% 31 Dec 2014 10-K 30 Mar 2016
Q1 2014 $4.55M -$42.8K -0.93% 31 Mar 2014 10-Q 14 May 2014
Q4 2013 $36.4K -$4.64M -99.2% 31 Dec 2013 10-K 30 Mar 2015
Q3 2013 $4.44M -$296K -6.25% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $4.49M 30 Jun 2013 10-Q 14 Aug 2013
Q1 2013 $4.6M 31 Mar 2013 10-Q 15 May 2013
Q4 2012 $4.68M +$4.63M +10067% 31 Dec 2012 10-K 27 Mar 2014
Q3 2012 $4.74M 30 Sep 2012 10-Q/A 22 Jan 2013
Q4 2011 $46K 31 Dec 2011 10-K 28 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.